About SelfDecode
SelfDecode is a company based in San Luis Obispo (United States) founded in 2016. SelfDecode has raised $8 million across 1 funding round from investors including Igor Lychagov and Dan Magnuszewski. SelfDecode offers products and services including SelfDecode DNA Kit, AI Health Coach, and Health Reports. SelfDecode operates in a competitive market with competitors including Helix, Counsyl, InformedDNA, Arivale and Digbi Health, among others.
- Headquarter San Luis Obispo, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genius Labs Co
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8 M (USD)
in 1 rounds
-
Latest Funding Round
$8 M (USD), Series A
Nov 16, 2021
-
Investors
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SelfDecode
SelfDecode offers a comprehensive portfolio of products and services, including SelfDecode DNA Kit, AI Health Coach, and Health Reports.
Provides genetic analysis for personalized health and ancestry reports.
Delivers personalized health advice based on DNA and user data.
Generates insights on genetic risks and lifestyle recommendations.
People of SelfDecode
Unlock access to complete
Funding Insights of SelfDecode
SelfDecode has successfully raised a total of $8M through 1 strategic funding round. The most recent funding activity was a Series A round of $8 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $8.0M
-
First Round
First Round
(16 Nov 2021)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series A - SelfDecode | Valuation | Igor Lychagov |
Investors in SelfDecode
SelfDecode has secured backing from 2 investors, including angel investors. Prominent investors backing the company include Igor Lychagov and Dan Magnuszewski.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
IL
Igor Lychagov |
-
|
Founded Year | Domain | Location |
|
DM
Dan Magnuszewski |
Angel investor and tech entrepreneur, co-founder of Dockwa, active in startups
|
Founded Year | Domain | Location |
Investments & Acquisitions by SelfDecode
Financial Statements - SelfDecode
Selfdecode Comparisons
Competitors of SelfDecode
SelfDecode operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Counsyl, InformedDNA, Arivale and Digbi Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic database for clinical research is provided.
|
|
| domain | founded_year | HQ Location |
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
|
|
| domain | founded_year | HQ Location |
Network of genetics experts provided to assist patients and providers.
|
|
| domain | founded_year | HQ Location |
Provider of direct-to-consumer genetic testing.
|
|
| domain | founded_year | HQ Location |
Personalized healthcare is delivered through DNA and gut biome testing.
|
|
| domain | founded_year | HQ Location |
Provider of a platform for gene analysis to determine genetic diseases and drug response
|
Frequently Asked Questions about SelfDecode
SelfDecode was founded in 2016 and raised its 1st funding round 5 years after it was founded.
SelfDecode is headquartered in San Luis Obispo, United States. It is registered at San Luis Obispo, California, United States.
SelfDecode is a funded company, having raised a total of $8M across 1 funding round to date. The company's 1st funding round was a Series A of $8M, raised on Nov 16, 2021.
SelfDecode was established in 2016 in San Luis Obispo, United States, within the personal genomics sector. Genome sequence data from external services is uploaded by users and processed on company servers to produce variant reports. A software platform is employed to facilitate customized report generation and assessment of mutation effects on overall health, wellness, and related factors. Operations focus on data analysis and user tools for genetic insights.
SelfDecode's top competitors include Helix, Digbi Health and InformedDNA.
SelfDecode offers SelfDecode DNA Kit, AI Health Coach, and Health Reports.
SelfDecode has 2 investors. Key investors include Igor Lychagov, and Dan Magnuszewski.